J&J unit, Danish biotech firm sign drug development deal

08/17/2009 | Forbes

Johnson & Johnson's Janssen Pharmaceutica is partnering with Danish biotech firm NeuroSearch to develop and market drugs for central nervous system diseases. Under the collaboration, Neurosearch is entitled to receive $45.68 million in income and funding from Janssen during the first three years and up to $300 million in milestone fees and royalties.

View Full Article in:

Forbes

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Senior Attorney
Blue Cross Blue Shield of Louisiana
Baton Rouge, LA
Director, Payer Marketing
Avalere Health
Washington, DC
Senior Vice President
Health Alliance Plan of Michigan
Southfield, MI
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX